A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma

Clinical trial NCT00554372 · COMPLETED

Trial details

NCT number: NCT00554372
Sponsor: Jennerex Biotherapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2008-08-01
Primary completion: 2011-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.